APA (7th ed.) Citation

Gabrilove, J. L., Perez, E. A., Tomita, D. K., Rossi, G., & Cleeland, C. S. (2007). Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: Results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks. Cancer, 110(7), 1629. https://doi.org/10.1002/cncr.22943

Chicago Style (17th ed.) Citation

Gabrilove, Janice L., Edith A. Perez, Dianne K. Tomita, Greg Rossi, and Charles S. Cleeland. "Assessing Symptom Burden Using the M. D. Anderson Symptom Inventory in Patients with Chemotherapy-induced Anemia: Results of a Multicenter, Open-label Study (SURPASS) of Patients Treated with Darbepoetin-alpha at a Dose of 200 Microg Every 2 Weeks." Cancer 110, no. 7 (2007): 1629. https://doi.org/10.1002/cncr.22943.

MLA (9th ed.) Citation

Gabrilove, Janice L., et al. "Assessing Symptom Burden Using the M. D. Anderson Symptom Inventory in Patients with Chemotherapy-induced Anemia: Results of a Multicenter, Open-label Study (SURPASS) of Patients Treated with Darbepoetin-alpha at a Dose of 200 Microg Every 2 Weeks." Cancer, vol. 110, no. 7, 2007, p. 1629, https://doi.org/10.1002/cncr.22943.